A Breakthrough in Renal Failure : The Science of PRO® A Granules - Salah, Sherif
34,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
17 °P sammeln
  • Broschiertes Buch

Chronic kidney disease (CKD) affects millions worldwide, with advanced stages leading to debilitating complications from the buildup of urea, creatinine, and uric acid. While dialysis sustains life, it imposes heavy burdens on patients' quality of life and healthcare systems.This book introduces PRO® A granules, an innovative treatment using antibody-coated psyllium to bind and remove harmful waste products. Breakthrough trials revealed reductions of up to 80% in creatinine and 70% in urea, offering a transformative alternative to traditional dialysis. Delving into the science, research, and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Chronic kidney disease (CKD) affects millions worldwide, with advanced stages leading to debilitating complications from the buildup of urea, creatinine, and uric acid. While dialysis sustains life, it imposes heavy burdens on patients' quality of life and healthcare systems.This book introduces PRO® A granules, an innovative treatment using antibody-coated psyllium to bind and remove harmful waste products. Breakthrough trials revealed reductions of up to 80% in creatinine and 70% in urea, offering a transformative alternative to traditional dialysis. Delving into the science, research, and potential of PRO® A granules, this work sheds light on a promising path forward for CKD treatment, inspiring hope and progress in renal care.This book is more than a scientific exploration; it is a call to action for researchers, clinicians, and innovators. By shining a light on the revolutionary potential of PRO® A granules, we aim to inspire hope, spark progress, and ultimately redefine thefuture of renal care.
Autorenporträt
El Dr. Sherif Salah es un reputado científico y consultor en patología clínica con un doctorado en inmunología y múltiples diplomas de la Universidad de El Cairo. Innovador en el campo farmacéutico, es autor de libros y artículos sobre el VIH, el cáncer, el Parkinson, el Alzheimer y los tratamientos con COVID-19. Actualmente se centra en la terapia del cáncer y el diagnóstico precoz. Actualmente se centra en la terapia del cáncer y el diagnóstico precoz.